News

04.09.2025

IIMT researchers discover a molecule that protects the liver against fulminant hepatitis

A team from the Institute of Translational Medicine Research (IIMT – CONICET / Universidad Austral) validated a new experimental therapeutic strategy that could benefit patients with severe liver disease. In an important...